Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC009133.23 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | AC009336.19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | AC015688.3 | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
mRNA | AC018902.1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | AC024361.1 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | AC087350.1 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | AC090094.1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | AC096949.1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AC104534.3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | AC104581.1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |